Skip to Content

BMS 100 mg 3623 (Reyataz 100 mg)

Generic Name: atazanavir

Pill with imprint BMS 100 mg 3623 is Blue & White, Capsule-shape and has been identified as Reyataz 100 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for BMS 100 mg 3623

Reyataz

Generic Name
atazanavir
Imprint
BMS 100 mg 3623
Strength
100 mg
Color
Blue & White
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Protease inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
National Drug Code (NDC)
00003-3623
Inactive Ingredients
crospovidone, lactose monohydrate, magnesium stearate, gelatin, FD&C Blue No. 2, titanium dioxide, ferric oxide red, ferric oxide yellow, isopropyl alcohol, ammonia, propylene glycol, butyl alcohol, alcohol, ferrosoferric oxide, shellac

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.